The Annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) was held from May 5-9, 2013, in Seattle, USA. The event was organized to facilitate the advancement of basic and clinical vision research with a goal of prevention and cure of ophthalmic disorders in the world. The conference started with a brief introduction by course coordinator after which in the first session 'Diabetic Retinopathy: Where Do We Stand and Where Do We Go from Here?, 'Entrepreneurship in Ophthalmology: Pathways to Innovation, Ophthalmic Oncology Update: Molecular Signature of Ocular and Orbital Tumors and Targeted Biologic Treatment Opportunities, Predicting, Measuring and Treating Changes in Corneal Biomechanics' were discussed. This course led to discussion about both basic and clinical sciences of diabetic retinopathy. The role of cancer stem cells and molecular characteristics of ocular tumor that may lead to targeted therapy was also discussed.

doi : 10.5214/ans.0972.7531.200410